Every recall we track for North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding — 7 in all — plus the complaints and injury reports the public filed about them.
FarmaKeio recalls LL-37 2 mg/mL (5 mL) injections due to potential sterility issues. Products may not be sterile, risking infections. Affected lots from April 2022.
FarmaKeio recalls BPC-157 2mg/mL injections due to potential sterility issues. This affects sterile medical products made under questionable manufacturing practices.
FarmaKeio recalls Sermorelin Acetate 1 mg/mL injections due to potential sterility issues. Affected lots from 4/12/2022 to 6/7/2022. Stop using if you have these vials.
FarmaKeio recalls 10mL vials of Ipamorelin/Sermorelin injections due to potential sterility issues. Products may cause infections if used without proper sterility.
FarmaKeio recalls 10mL Melanotan II injections due to potential sterility issues. Products may cause infections if used without proper sterility.
FarmaKeio recalls ARA-290 (Cibinetide Acetate) 6 mg/mL injections due to potential sterility issues. This affects specific lot numbers sold in Texas. Patients should contact their doctor for guidance.
FarmaKeio recalls PT-141 (Bremelanotide Acetate) 10 mg/mL injections due to potential sterility issues. Products may not be sterile, risking infections. Check lot numbers on vials for affected items.
